Suspended

Robotic-Assisted Treadmill Training for Gait Restoration in Hemiparetic Stroke Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Brain Diseases+8

+ Cardiovascular Diseases

+ Central Nervous System Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 1
Interventional
Study Start: November 2002
See protocol details

Summary

Principal SponsorU.S. Department of Education
Study ContactCheryl M Lacsamana, BBE
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 1, 2002

Actual date on which the first participant was enrolled.

This study focuses on improving the walking ability of individuals who have experienced a stroke, specifically those with hemiparesis - a condition causing weakness on one side of the body. The study aims to compare two different types of walking therapy. One is a conventional method that includes leg strengthening exercises, stretching, and walking with a therapist's assistance. The other method uses a special treadmill called Lokomat, which works with lightweight robotic arms to help move the legs while walking. The study's importance lies in its potential to find effective ways to restore gait in stroke patients, enhancing their mobility and quality of life.

Official TitleGait Restoration In Hemiparetic Stroke Patients Using Goal-Directed, Robotic-Assisted, Treadmill Training
NCT00075283
Principal SponsorU.S. Department of Education
Study ContactCheryl M Lacsamana, BBE
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Brain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersNervous System DiseasesNeurologic ManifestationsParesisSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesStroke

Criteria

Inclusion: * Unilateral brain lesion. * Within 6 months post-stroke. * Receiving no other therapy targeting function of lower limb. * Demonstration of hemiparesis (motor dysfunction in lower limb). * Able to walk 5 meters without therapist assistance (walking device only). * Able to follow commands and protocol. Exclusion: * Significant cognitive or communication impairments. * Uncontrolled hypertension. * Uncontrolled diabetes. * Clinical depression.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

National Rehabilitation Hospital

Washington D.C., United StatesOpen National Rehabilitation Hospital in Google Maps
SuspendedOne Study Center